Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Communication Cable Systems Indonesia Tbk. (CCSI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Communication Cable Systems Indonesia Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Communication Cable Systems Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Communication Cable Systems Indonesia Tbk. trades at Rp262 (market cap 349.33B, 506.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 36× Communication Cable Systems Indonesia Tbk.'s market cap, and Communication Cable Systems Indonesia Tbk. is more actively traded (506.7K versus 235.2K). Which is the better fit depends on your goals.

CCSITSPC
Market Cap
349.33B12.58T
Volume
506.7K235.2K
Lot
5.07K2.35K
Turnover
133.49M649.94M
Average Price
263.452,763.37
Value
133.49M649.94M
Indicative Equilibrium Price
2582,780
Indicative Equilibrium Volume
149

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CCSI
View details
TSPC
View details

About Communication Cable Systems Indonesia Tbk.

PT Communication Cable Systems Indonesia Tbk (the Entity) Tbk formerly PT Siemens Kabel Optik was established under the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11/1970, and most recently amended by Capital Investment No. 25/2007, based on the Notarial Deed No. 66 of Trisnawati Mulia, S.H., dated October 11, 1995.

Read more on CCSI

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC